Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07274423Recruiting

Clinical Value of Deep Learning Reconstruction Technology in Ankle MRI

Role: lead

NCT07274436Recruiting

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

Role: lead

NCT07251946Completed

Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer

Role: lead

All 3 trials loaded